Company Search:
Advanced Search
Sponsored Links
Calliditas Therapeutics AB Company Snapshot
Calliditas Therapeutics AB operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Calliditas Therapeutics AB with three other companies in this sector in SWEDEN : Camurus AB (2019 sales of 105.61 million Swedish Kronor [US$12.11 million] of which 68% was Sales of development related goods and s), Swedencare AB (publ) (126.87 million Swedish Kronor [US$14.55 million] of which 67% was PlaqueOff Powder), and Enzymatica AB (publ) (61.31 million Swedish Kronor [US$7.03 million] of which 100% was Medical Devices).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Calliditas Therapeutics AB
  Stock Performance Chart for Calliditas Therapeutics AB
  Stock Data: Recent Stock Performance:
  Current Price (7/31/2020): 102.40
(Figures in Swedish Kronor)
1 Week -5.7%   13 Weeks -6.1%  
4 Weeks 3.0%   52 Weeks 79.6%  
Calliditas Therapeutics AB Key Data:
  Ticker: CALTX Country: Sweden
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2019 Sales 184,829,000
(Year Ending Jan 2020).
Employees: 14
  Currency: Swedish Kronor Market Cap: 3,963,662,131
  Fiscal Yr Ends: December Shares Outstanding: 38,707,638
  Share Type: Aktie Closely Held Shares: 14,150,128
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.